Cardiol Therapeutics Inc. (CRDL): key financial figures for fiscal year 2025 (in CAD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2025)
- -CA$33.8M
- Total Assets (FY2025)
- CA$23.6M
- Total Equity (FY2025)
- CA$17.9M
- Cash Flows from Operating Activities (FY2025)
- -CA$23.9M
Source: Cardiol Therapeutics Inc. 40-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
